open access

Vol 7, No 2 (2003)
REVIEV
Published online: 2003-03-24
Get Citation

Microalbuminuria. Epidemiology, pathogenesis, clinical role

Bogdan Wyrzykowski
Nadciśnienie tętnicze 2003;7(2):87-98.

open access

Vol 7, No 2 (2003)
REVIEV
Published online: 2003-03-24

Abstract

Microalbuminuria is defined as increased urinary albumin secretion which is not detectable by standard diagnostic methods. The incidence of microalbuminuria is estimated to be 20-30% in diabetes patients, 15% in hypertensive patients, and about 4-5% in patients without diabetes or hypertension. Microalbuminuria may not only reflect renal malfunction but can also be a marker of generalised angiopathy. In diabetes and hypertension microalbuminuria is a useful marker of changes in the cardiovascular system that are already present and can indicate the risk of future cardiovascular events. Rigorous control of blood pressure in diabetes patients diminishes microalbuminuria and slows down the progression of nephropathy and the development of end-stage renal insufficiency. It is uncertain whether decreased urinary albumin secretion in hypertensive patients is associated with similar benefits. The data available suggest that the most effective reduction in microalbuminuria is obtained from ACE inhibitors. Evidence from the NESTOR trial shows that Indapamid SR may be as effective as ACE-I in diabetes type 2 patients and hypertensive patients.

Abstract

Microalbuminuria is defined as increased urinary albumin secretion which is not detectable by standard diagnostic methods. The incidence of microalbuminuria is estimated to be 20-30% in diabetes patients, 15% in hypertensive patients, and about 4-5% in patients without diabetes or hypertension. Microalbuminuria may not only reflect renal malfunction but can also be a marker of generalised angiopathy. In diabetes and hypertension microalbuminuria is a useful marker of changes in the cardiovascular system that are already present and can indicate the risk of future cardiovascular events. Rigorous control of blood pressure in diabetes patients diminishes microalbuminuria and slows down the progression of nephropathy and the development of end-stage renal insufficiency. It is uncertain whether decreased urinary albumin secretion in hypertensive patients is associated with similar benefits. The data available suggest that the most effective reduction in microalbuminuria is obtained from ACE inhibitors. Evidence from the NESTOR trial shows that Indapamid SR may be as effective as ACE-I in diabetes type 2 patients and hypertensive patients.
Get Citation

Keywords

microalbuminuria; diabetes; hypertension; cardiovascular risk; nephropathy

About this article
Title

Microalbuminuria. Epidemiology, pathogenesis, clinical role

Journal

Arterial Hypertension

Issue

Vol 7, No 2 (2003)

Pages

87-98

Published online

2003-03-24

Bibliographic record

Nadciśnienie tętnicze 2003;7(2):87-98.

Keywords

microalbuminuria
diabetes
hypertension
cardiovascular risk
nephropathy

Authors

Bogdan Wyrzykowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl